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Abstract
Evidence from human studies and transgenic mice lacking the type 3 adenylyl cyclase (AC3) indicates that AC3 plays a role in the regulation of body weight. It is
unknown in which brain region AC3 exerts such an effect. We examined the role of AC3 in the hypothalamus for body weight control using a floxed AC3 mouse
strain. Here, we report that AC3 flox/flox mice became obese after the administration of AAV-CRE-GFP into the hypothalamus. Both male and female AC3
floxed mice showed heavier body weight than AAV-GFP injected control mice. Furthermore, mice with selective ablation of AC3 expression in the ventromedial
hypothalamus also showed increased body weight and food consumption. Our results indicated that AC3 in the hypothalamus regulates energy balance.

Introduction
Obesity is a major health issue associated with complications
that cause significant morbidity and mortality. Obese individuals
have a higher risk for a number of diseases including type 2 diabetes,
cardiovascular disease, metabolic syndrome, hypertension, certain
forms of cancer, and sleep-breathing disorders [1]. Furthermore,
obesity decreases longevity and lowers the general quality of life [2-5].
Although intensive effort has been devoted to anti-obesity therapy, the
percentage of obese individuals in industrialized countries continues
to increase.
Adenylyl cyclases (ACs) catalyze the synthesis of cyclic 3’5’-AMP
(cAMP) from ATP. There are ten AC isoforms that have been cloned
and characterized in mammals [6]. It has been reported that AC3 gene
polymorphisms are associated with obesity in a group of Swedish
men [7]. In another study, a genome-wide association analysis based
on height-adjusted BMI found that SNPs in AC3 were associated at
genome-wide significance level (rs11676272 (0.28 kg/m3.1 change
per allele G (0.19, 0.38), P56 3 1029). The association signal at AC3
is apparently driven by a miss-sense variant [8]. These human genetic
studies suggested that AC3 might play an important role in the
regulation of body weight. Previous studies from our lab showed that
a global AC3 mouse knockout exhibit adult onset obesity [9]. They
show increased fat mass, larger adipocytes, reduced physical activity,
increased food consumption, and leptin insensitivity. Subsequently, it
was discovered that a gain of function mutation in AC3 protects mice
from diet-induced obesity providing further evidence that AC3 may
play a major role in weight control [10]. However, why AC3-/- mice are
obese remains unclear.
AC3 is expressed throughout the nervous system and AC3-/- mice
exhibit a number of other phenotypes including anosmia, depression,
and defects in extinction of hippocampus dependent memory that
confound interpretation of the obesity phenotype in the global AC3
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knockout. The importance of the hypothalamus in regulating energy
balance has been well established [11-13]. For example, ablation of the
ventromedial nuclei of the hypothalamus causes overeating and obesity
[14]. Since AC3 is expressed in several tissues and various areas of
the brain including the hypothalmus, the goal of this project was to
determine if AC3 ablation in the hypothalamus causes adult onset
obesity using a floxed AC3 mouse strain.

Methods
Mice
Mice were housed at 22–24°C with a 12-h light/dark cycle, and
had access to food and water ad libitum. The age of animals used in
this study was 2 - 4 months old. AC3 lox/lox mice were generated as
previously reported [15]. All animal procedures were approved by the
Institutional Animal Care and Use Committee at the University of
Washington and performed in accordance with their guidelines.

Body weight and food consumption
Body weight was monitored before virus injection, then weekly
after injection. Food intake was measured daily on the fourth week
after virus injection.

Immunofluorescene
Immunofluorescene procedures were performed as described
previously with a few modifications [9]. Mice were perfused with 4%
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paraformaldehyde (PFA). The brains were then dissected and postfixed
with the same fixing solution overnight at 4°C. Then the brains were
cryoprotected with 30% sucrose for 48 hr at 4°C. Brains were cut into
30 mm sections with a cryostat freezing microtome. Floating sections
were blocked and then first incubated with the AC 3 antibody (1:500,
Santa Cruz Biotechnology, Inc.) overnight at 4°C followed by the
secondary antibody, Alexa Fluor 488-conjugated donkey anti-rabbit
IgG (Invitrogen, La Jolla, CA), for 2 hr at room temperature. Stained
sections were mounted onto microscopy slides and visualized by
confocal microscopy (Zeiss 510 META).

Stereotaxic viral injection
AAV1-Cre-GFP and AAV1- GFP were bilaterally injected into the
hypothalamus (2.2 × 1011 viral genome per microliter) of 4-wk-old AC3
lox/lox mice. According to previous report [16], four-site injections of
0.5 μL per site were performed for each side at the coordinates x = ± 0.5,
y = −1.4, and z = −5.6 and −5.0, which corresponds to ventral and dorsal
hypothalamus, respectively. For the VMH injection, two-site injections
were performed for each side at the coordinates x = ± 0.5, y = −1.4,
and z = −5.6. GFP fluorescence was used to identify the virally infected
areas. AC3 immunohistochemistry was used to show the expression of
AC3. Body weight was monitored before and after virus injection for
each mouse. Results from animals that received injections at the correct
site as determined by GFP fluorescence were included in analyses.

Statistical analysis
All data are expressed as means ± SEM. Data from food
consumption were analyzed using the unpaired Student’s t test. For
body weight curves, the data were analyzed with two-way ANOVA
followed by Holm-Sidak Test. P<0.05 was considered to be statistically
significant.

Results
To investigate the role of AC3 in the hypothalamus for regulation
of body weight, we injected a recombinant virus AAV-CRE-GFP
bilaterally into the hypothalamus of AC3 lox/lox mice, which deletes
AC3 expression specifically in the hypothalamus. As showed in
Figure 1, AAV-CRE-GFP injected mice showed an obvious weight
gain compared to AAV-GFP injected mice 10 weeks later. Both male
(Figure 1C) and female (Figure 1D) mice that received the AAV1CRE-GFP construct were significantly heavier than floxed AC3 mice
that received an AAV-GFP construct as a control during the period
examined (Male, Two way ANOVA, F(1, 170) = 42.67, P < 0.001 N=9 for
both groups; Female, Two way ANOVA, F(1, 137) = 54.6123, P < 0.001;
N=8 for GFP control group and N=7 for CRE-GFP group). Adult
male floxed AC3 with AAV-CRE-GFP injection are about 20% heavier
that the floxed mice with AAV-GFP injection, while female floxed
AC3 mice are 40% heavier. In addition, the AC3 flox/flox mice with

Figure 1. AC3 in the hypothalamus contributes to obesity. A. Representative mice at weeks 10 after AAV-GFP and AAV-GFP-CRE injections. B. Daily food consumption of AC3 lox/lox
mice with AAV-GFP and AAV-GFP-CRE injections. C-D.Body weight in female (C), Male (D) mice after introhypothalamus injection of AAV-GFP and AAV-GFP-CRE.
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AAV1-CRE-GFP injection consumed twice as much food daily than
the control mice, suggesting that increased food consumption may
contribute to the obesity of AC3 floxed mice with AAV-CRE injection.
(CRE-GFP vs. GFP (g): 10.26 ± 0.58 vs 4.86 ± 0.31, P < 0.001)(Figure
1B). We verified that AC3 expression in the hypothalamus was reduced
when AAV1-CRE-GFP was injected into the hypothalamus of floxed
AC3 mice using a ployclonal antibody against AC3 (Figure 2).

Therefore, we selectively disrupted AC3 expression in the VMH by
injecting AAV1-CRE-GFP to explore whether loss of AC3 in the VMH
contributes to obesity (Figure 3). Mice with AAV1-CRE-GFP VMH
injection exhibited significant heavier body weight (Two way ANOVA,
F(1, 141)=73.017, P < 0.001, N=7 for control group and N=8 for AAVCRE-GFP injected group) , higher food consumption (CRE-GFP vs
GFP, 7.856 ± 0.718 vs 5.126 ± 0.257, P =0.005).

Several different sites within the hypothalamus are known to be
important in regulating body weight including the ventromedial
hypothalamic nucleus (VMH). For example, bilateral lesions of the
VMH in rats produced a severe hyperphagic obesity syndrome.

Discussion
The hypothalamus plays a central role in maintaining energy
homeostasis. Different hypothalamic nuclei, including the arcuate
nucleus (ARC), dorsomedial hypothalamus (DMH), ventromedial
hypothalamus (VMH), paraventricular nucleus (PVN), and lateral
hypothalamic area (LH) have been demonstrated to have specific
functions in the regulation of energy balance [11-13]. Earlier evidence
has reported that lesions in the VMH produced robust increases in
adiposity, caused obesity, and in some strains, diabetes [14,17]. In the
present study, we found proved that selective ablation of AC3 in the
hypothalamus caused obesity. Interestingly, selective ablation of AC3
in the hypothalamus VMH lead to obesity.
It has been reported that AC3 gene polymorphisms are associated
with obesity in humans [7,8]. We previously reported that disruption
of the AC3 gene in mice cause obesity as they aged. Adult male AC3/mice are about 40% heavier than wild type male littermates while
female AC3-/- mice are 70% heavier. The gain in weight is due to an
increase in body fat. Although lipolysis is unaltered in AC3-/- mice,
their additional weight is due to leptin insensitivity, increased fat
mass and larger adipocytes. Before the onset of obesity, young AC3/mice (2 months) exhibit reduced physical activity, increased food
consumption, and leptin insensitivity [9]. This suggests that the obesity
of AC3-/- may be due to loss of AC3 in the hypothalamus. To address
this issue we made a floxed AC3 mouse for the selective disruption of
AC3 expression in various areas of the CNS [15].

Figure 2. The immunohisto chemistry showing AC3 (red) expression in the hypothalamus
following AAV-GFP injection (A and B) and AAV-GFP-CRE injections (C and D), DAPI
(blue), GFP (green) and AC3 (red). Injection site: AP -1.46 mm posterior to Bregma; ML
±0.5 mm; DV -5.0 & -5.5 mm.

Selective ablation AC3 expression in AC3 flox/flox mice using
VMH-injection of AAV-CRE-GFP significantly increased the body
weight, supporting the hypothesis that AC3 in the ventromedial
hypothalamus plays an important role in control of weight. A possible
contributor to obesity caused by AC3 ablation is leptin insensitivity.
Leptin can act in the hypothalamus to reduce food intake and increase

Figure 3. The mice with specific ventromedial hypothalamus injection of AAV-GFP-CRE develop obesity. A. The body weight of AC3 lox/lox mice with VMH injection of AAV-GFP and
AAV-GFP-CRE respectively. B. Daily food consumption of AC3 lox/lox mice after AAV-GFP and AAV-GFP-CRE injections.
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physical activity [18]. The leptin receptor is a JAK-STAT receptor and
it is not directly coupled to adenylyl cyclase activity. The role of AC3
in leptin insensitivity is therefore likely to be downstream of the leptin
receptors in the ventromedial hypothalamus. It has been reported that
the VMH mediates the leptin-induced increase in glucose utilization
as well as its insulin sensitivity in the whole body through activation
of the melanocortin receptor (MCR). Leptin sensitivity is due, in part,
to production of alpha-MSH which stimulates adenylyl cyclase activity
in MC4-R-expressing neurons in the ventromedial hypothalamus [19].
POMC neurons originating in the arcuate nucleus contact synaptically
at MC4-R containing neurons in the VMH or other hypothalamic nuclei
that participate in control of feeding behavior [19]. The importance
of MC4-Rs in control of body weight is illustrated by the presence of
extreme obesity in MC4-R gene knockout mice and in humans with
mutations in MC4-R [20,21]. Furthermore, the injection of agonists of
the MC4-R ICV into mice significantly depresses food consumption
while chronic blockade of MC4-R causes obesity [22]. Since AC3 is one
of the major adenylyl cyclases expressed in the hypothalamus and AC3-/- mice
exhibit obesity, it is possible that MC4-R receptors normally couple to
stimulation of AC3 in neurons of the VMH to generate cAMP signals
which lead to appetite suppression and/or energy utilization. Hence,
the obesity of AC3 flox/flox mice after AAV-CRE-GFP administration
may be due to loss of cAMP production in VMH neurons in response
to melanocortins, thereby leading to obesity. Taken together, our
results indicated that AC3 might be a potential drug target site to
combat obesity.
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